Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,049 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Androgenetic alopecia and prostate cancer: findings from an Australian case-control study.
Giles GG, Severi G, Sinclair R, English DR, McCredie MR, Johnson W, Boyle P, Hopper JL. Giles GG, et al. Cancer Epidemiol Biomarkers Prev. 2002 Jun;11(6):549-53. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12050096
After hMSH2 and hMLH1--what next? Analysis of three-generational, population-based, early-onset colorectal cancer families.
Jenkins MA, Baglietto L, Dite GS, Jolley DJ, Southey MC, Whitty J, Mead LJ, St John DJ, Macrae FA, Bishop DT, Venter DJ, Giles GG, Hopper JL. Jenkins MA, et al. Int J Cancer. 2002 Nov 10;102(2):166-71. doi: 10.1002/ijc.10670. Int J Cancer. 2002. PMID: 12385013
Early growth, adult body size and prostate cancer risk.
Giles GG, Severi G, English DR, McCredie MR, MacInnis R, Boyle P, Hopper JL. Giles GG, et al. Int J Cancer. 2003 Jan 10;103(2):241-5. doi: 10.1002/ijc.10810. Int J Cancer. 2003. PMID: 12455039
Average age-specific cumulative risk of breast cancer according to type and site of germline mutations in BRCA1 and BRCA2 estimated from multiple-case breast cancer families attending Australian family cancer clinics.
Scott CL, Jenkins MA, Southey MC, Davis TA, Leary JA, Easton DF, Phillips KA, Hopper JL. Scott CL, et al. Hum Genet. 2003 May;112(5-6):542-51. doi: 10.1007/s00439-003-0908-6. Epub 2003 Feb 25. Hum Genet. 2003. PMID: 12601471
Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations.
Dite GS, Jenkins MA, Southey MC, Hocking JS, Giles GG, McCredie MR, Venter DJ, Hopper JL. Dite GS, et al. J Natl Cancer Inst. 2003 Mar 19;95(6):448-57. doi: 10.1093/jnci/95.6.448. J Natl Cancer Inst. 2003. PMID: 12644538
Regressive logistic and proportional hazards disease models for within-family analyses of measured genotypes, with application to a CYP17 polymorphism and breast cancer.
Cui JS, Spurdle AB, Southey MC, Dite GS, Venter DJ, McCredie MR, Giles GG, Chenevix-Trench G, Hopper JL. Cui JS, et al. Genet Epidemiol. 2003 Apr;24(3):161-72. doi: 10.1002/gepi.10222. Genet Epidemiol. 2003. PMID: 12652520
The HER2 I655V polymorphism and risk of breast cancer in women < age 40 years.
Montgomery KG, Gertig DM, Baxter SW, Milne RL, Dite GS, McCredie MR, Giles GG, Southey MC, Hopper JL, Campbell IG. Montgomery KG, et al. Cancer Epidemiol Biomarkers Prev. 2003 Oct;12(10):1109-11. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 14578152
Log odds of carrying an Ancestral Mutation in BRCA1 or BRCA2 for a Defined personal and family history in an Ashkenazi Jewish woman (LAMBDA).
Apicella C, Andrews L, Hodgson SV, Fisher SA, Lewis CM, Solomon E, Tucker K, Friedlander M, Bankier A, Southey MC, Venter DJ, Hopper JL. Apicella C, et al. Breast Cancer Res. 2003;5(6):R206-16. doi: 10.1186/bcr644. Epub 2003 Aug 28. Breast Cancer Res. 2003. PMID: 14580256 Free PMC article.
Body size and composition and prostate cancer risk.
MacInnis RJ, English DR, Gertig DM, Hopper JL, Giles GG. MacInnis RJ, et al. Cancer Epidemiol Biomarkers Prev. 2003 Dec;12(12):1417-21. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 14693731
1,049 results
Jump to page
Feedback